Home > Healthcare > Biotechnology > Biotechnology R&D > Gene Expression Market
Gene Expression Market size was valued at USD 12.5 billion in 2023 and is expected to grow at a CAGR of 7.1% between 2024 and 2032, propelled by factors such as the technological advancements and a growing emphasis on personalized medicine. Also, the growing prevalence of chronic diseases such as cancer, cardiovascular diseases, and neurological disorders contribute significantly to the growth of the market.
Altered gene expression plays a critical role in cancer development and progression. This involves activation of oncogenes and inactivation of tumor suppressor genes through various mechanisms, including genetic mutations, epigenetic modifications, and dysregulated signalling pathways. For instance, as per the Pan American Health Organization (PAHO), it is anticipated that around 20 million new cases and 10 million fatalities will arise in 2023, and annual reported cases are expected to reach about 30 million by 2040.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Gene Expression Market Size in 2023: | USD 12.5 Billion |
Forecast Period: | 2024 to 2032 |
Forecast Period 2024 to 2032 CAGR: | 7.1% |
2032 Value Projection: | USD 22.9 Billion |
Historical Data for: | 2018 – 2023 |
No. of Pages: | 230 |
Tables, Charts & Figures: | 381 |
Segments covered: | Process, Product, Application, Technique, Capacity, End-user, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
Gene expression is the process where information encoded in a gene is used to synthesize a functional gene product, such as a protein or RNA molecule. Further, gene expression analysis involves the measurement of the activity (expression) of genes in a biological sample to understand how different genes are turned on or off in response to various conditions. It aims to quantify the amount of mRNA produced from each gene, providing insights into the regulation and functioning of the genome.